×
About 3,555 results

ALLMedicine™ Digestive Disease Center

Research & Reviews  1,109 results

Fistula Laser Closure (FiLaC™) for fistula-in-ano-yet another technique with 50% healin...
https://doi.org/10.1007/s00384-021-03932-8 10.1007/s10151-011-0726-0 10.1007/s10151-017-1599-7 10.1007/s10151-020-02165-1 10.1111/codi.15148 10.1007/s10151-019-02112-9 10.1097/DCR.0000000000000067 10.1007/s10151-018-1885-z 10.1007/s10151-019-02077-9 10.1002/bjs5.50129 10.1016/j.ijsu.2017.08.582 10.1111/codi.12440 10.1097/SLE.0000000000000774 10.1097/DCR.0000000000000885 10.1097/DCR.0000000000000831
International Journal of Colorectal Disease; Nordholm-Carstensen A, Perregaard H et. al.

Apr 21st, 2021 - Treatment of ano-cutaneous fistulas remains a therapeutic challenge. Fistula Laser Closure (FiLaC™) is a relatively new technique for the treatment of ano-cutaneous fistulas. This study aimed to determine the success rate of fistula closure using ...

Endoscopic cardial constriction with band ligation in the treatment of refractory gastr...
https://doi.org/10.1007/s00464-021-08397-y
Surgical Endoscopy; Li ZT, Ji F et. al.

Apr 21st, 2021 - Gastroesophageal reflux disease (GERD) is a common digestive disease, could cause extra-esophageal symptoms. Peroral endoscopic cardial constriction with band ligation (PECC-b) is a minimally invasive method for the treatment of GERD in recent yea...

National digestive disease specialists survey on cardiovascular risk management in non-...
https://doi.org/10.1111/liv.14807
Liver International : Official Journal of the Internation... Iruzubieta P, Arias-Loste MT et. al.

Feb 2nd, 2021 - Cardiovascular disease (CVD) is the main cause of mortality among non-alcoholic fatty liver disease (NAFLD) patients. The aim was to explore the level of knowledge and clinical management of cardiovascular risk (CVR) in NAFLD patients by Digestive...

Periodontal disease in preoperative patients with digestive cancer: a retrospective, si...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789498
BMC Oral Health; Matsuda S, Goi T et. al.

Jan 7th, 2021 - The careful preoperative oral assessment may be useful for safe surgery under general anesthesia. The purpose of this study was to investigate the presence of periodontitis in patients with malignant digestive disease before surgery under general ...

see more →

Guidelines  1 results

DDW Website
https://ddw.org/home

May 14th, 2019 - Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world's largest gathering of physicians, researchers and industry in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery....

see more →

Clinicaltrials.gov  1,421 results

Some Nasogastric Intubation Procedures Lead to Less Aerosolization Than Feared
https://www.medscape.com/viewarticle/952317

Jun 1st, 2021 - Nasogastric intubation for esophageal manometry or impedance monitoring does not generate significant aerosol particles and is associated with minimal droplet spread, according to a Belgian study presented at the annual Digestive Disease Week® (DD...

Sporebiotics Improve Functional Dyspepsia Symptoms
https://www.medscape.com/viewarticle/952315

Jun 1st, 2021 - Compared with placebo, sporebiotics significantly reduced postprandial distress, epigastric pain, and several other symptoms of functional dyspepsia, reported lead author Lucas Wauters, MD, PhD, of University Hospitals Leuven (Belgium), and collea...

Liver Transplant Outcomes Improving for US Patients With HIV/HCV
https://www.medscape.com/viewarticle/952065

May 27th, 2021 - While liver transplant outcomes were historically poor in people coinfected with HIV and hepatitis C virus (HCV), they have improved significantly in the era of direct-acting antiviral (DAA) therapy, a recent analysis of U.S. organ transplant data...

Microbiome Therapeutic Offers Durable Protection Against C difficile Recurrence
https://www.medscape.com/viewarticle/952113

May 27th, 2021 - SER-109, an oral microbiome therapeutic, safely protects against Clostridioides difficile recurrence for up to 24 weeks, according to a recent phase 3 trial. Three days of treatment with purified Firmicutes spores reduced risk of recurrence by 54%...

H pylori: High Eradication, Fewer Side Effects With Hybrid Therapy
https://www.medscape.com/viewarticle/952112

May 27th, 2021 - Dr Joseph Adrian L. Buensalido A 14-day course of hybrid therapy was as effective as 10-day bismuth quadruple therapy, but with fewer side effects, according to results of a randomized trial conducted in Taiwan. "However, the former had fewer adve...

see more →

News  999 results

Some Nasogastric Intubation Procedures Lead to Less Aerosolization Than Feared
https://www.medscape.com/viewarticle/952317

Jun 1st, 2021 - Nasogastric intubation for esophageal manometry or impedance monitoring does not generate significant aerosol particles and is associated with minimal droplet spread, according to a Belgian study presented at the annual Digestive Disease Week® (DD...

Sporebiotics Improve Functional Dyspepsia Symptoms
https://www.medscape.com/viewarticle/952315

Jun 1st, 2021 - Compared with placebo, sporebiotics significantly reduced postprandial distress, epigastric pain, and several other symptoms of functional dyspepsia, reported lead author Lucas Wauters, MD, PhD, of University Hospitals Leuven (Belgium), and collea...

Liver Transplant Outcomes Improving for US Patients With HIV/HCV
https://www.medscape.com/viewarticle/952065

May 27th, 2021 - While liver transplant outcomes were historically poor in people coinfected with HIV and hepatitis C virus (HCV), they have improved significantly in the era of direct-acting antiviral (DAA) therapy, a recent analysis of U.S. organ transplant data...

Microbiome Therapeutic Offers Durable Protection Against C difficile Recurrence
https://www.medscape.com/viewarticle/952113

May 27th, 2021 - SER-109, an oral microbiome therapeutic, safely protects against Clostridioides difficile recurrence for up to 24 weeks, according to a recent phase 3 trial. Three days of treatment with purified Firmicutes spores reduced risk of recurrence by 54%...

H pylori: High Eradication, Fewer Side Effects With Hybrid Therapy
https://www.medscape.com/viewarticle/952112

May 27th, 2021 - Dr Joseph Adrian L. Buensalido A 14-day course of hybrid therapy was as effective as 10-day bismuth quadruple therapy, but with fewer side effects, according to results of a randomized trial conducted in Taiwan. "However, the former had fewer adve...

see more →

Patient Education  25 results see all →